Christopher Rovaldi Keros Therapeutics, Inc. (KROS) insider trading activity
Christopher Rovaldi is CHIEF OPERATING OFFICER of Keros Therapeutics, Inc.. Currently has a direct ownership of 0 shares of KROS, which is worth approximately $0. The most recent transaction as insider was on Apr 06, 2022, when has been sold 1,728 shares (Common Stock) at a price of $65.0 per share, resulting in proceeds of $112,320. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).
Shares Held (Direct Ownership)
0
0%
3M change
0%
12M change
Total Value Held
$0
Christopher Rovaldi Transaction History
CR
Christopher Rovaldi
CHIEF OPERATING OFFICER
Lexington, MA